OOIR: Observatory of International Research

Papers

(The H4-Index of SLAS Discovery is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Fast Mek1 Hit Identification with TRIC Technology Correlates Well with Other Biophysical Methods	223
Combinatorial screen of targeted agents with the PI3K inhibitors inavolisib, alpelisib, duvelisib, and copanlisib in multi-cell type tumor spheroids	62
Magnetic three-dimensional bioprinting protocol for salivary gland mucoepidermoid carcinoma tumoroid culture	61
Green chemistry: Modern therapies using nanocarriers for treating rare brain cancer metastasis from colon cancer	42
Optimized scaffold-free human 3D adipose tissue organoid culture for obesity and disease modeling	40
A Phenotypic Approach for the Identification of New Molecules for Targeted Protein Degradation Applications	39
Ex vivo discovery of synergistic drug combinations for hematologic malignancies	36
Publisher's Note	30
Phenotypic Screening Following Transcriptomic Deconvolution to Identify Transcription Factors Mediating Axon Growth Induced by a Kinase Inhibitor	29
High-throughput approaches to uncover synergistic drug combinations in leukemia	28
SLAS special issue editorial 2022: 3D cell culture approaches of microphysiologically relevant models	27
High content screening miniaturization and single cell imaging of mature human feeder layer-free iPSC-derived neurons	27
Using measures of metabolic flux to align screening and clinical development: Avoiding pitfalls to enable translational studies	27
Multifunctional profiling of triple-negative breast cancer patient-derived tumoroids for disease modeling	27
In Vitro Ubiquitination Platform Identifies Methyl Ellipticiniums as Ubiquitin Ligase Inhibitors	26
Differential analyte derivatization enables unbiased MALDI-TOF-based high-throughput screening: A proof-of-concept study for the discovery of catechol-o-methyltransferase inhibitors	26
FLECS technology for high-throughput screening of hypercontractile cellular phenotypes in fibrosis: A function-first approach to anti-fibrotic drug discovery	25
Establishing and Validating Cellular Functional Target Engagement Assay for Selective IRAK4 Inhibitor Discovery	25
Approaches for Prioritizing High-Quality Chemical Matter in Chemical Probe and Drug Discovery	23
Screening approaches for the identification of Nrf2-Keap1 protein-protein interaction inhibitors targeting hot spot residues	22
A Novel High-Throughput FLIPR Tetra–Based Method for Capturing Highly Confluent Kinetic Data for Structure–Kinetic Relationship Guided Early Drug Discovery	22
A Quantitative Bioassay to Determine the Inhibitory Potency of NGF–TrkA Antagonists	22
BRET measurement on CCD camera-based microtiter plate readers	22